AHAmy Hardy

Amy Hardy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amy Hardy has a total of 308 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prolonged exposure, eye movement desensitization and reprocessing therapy, and cognitive restructuring versus waiting-list for individuals with PTSD and psychosis (RE.PROCESS): A multicenter, four-arm, assessor-masked, superiority randomized controlled trial

    by Simone R. Burger, Inez Verdaasdonk, Catherine van Zelst, Paul A.J. de Bont, Berber van der Vleugel, Anton B.P. Staring, Carlijn de Roos, Ad de Jongh, Eva Tolmeijer, Tineke van der Linden, et al.

    Background: Evidence indicates the potential efficacy of trauma-focused therapies for post-traumatic stress disorder (PTSD) in psychosis. This is the first randomized controlled trial to evaluate the superiority of Prolonged Exposure (PE), Eye Movement Desensitization and Reprocessing therapy (EMDR), and Cognitive Restructuring (CR) plus treatment as usual, compared to a waiting-list (WL) plus treatment as usual control group. Methods: We conducted a multicenter, assessor-masked, randomized controlled trial in patients with a lifetime schizophrenia spectrum psychotic disorder and PTSD. Participants ( N = 162) were randomized (1:1:1:1) to PE, EMDR, CR, or WL and followed up until 6 months post-randomization. Therapy conditions had a maximum of 16 twice-weekly sessions. Primary outcome was researcher-rated PTSD symptom severity (Clinician-Administered PTSD Scale for DSM-5; CAPS-5). Results: PE, EMDR, and CR significantly reduced PTSD severity compared to WL over time from baseline to 6-month follow-up. At 6-months, adjusted differences and between-group effect sizes on the CAPS-5 were −9.76 (95% CI −16.13,−3.38; p = 0.0029) with d = −0.90 (95% CI −1.36,−0.44) for PE, −11.74 (95% CI −18.04,−5.44; p = 0.0003) with d = −1.04 (95% CI −1.50,−0.58) for EMDR, and −12.72 (95% CI −18.89,−6.55; p = 0.0001) with d = −1.00 (95% CI −1.46,−0.54) for CR. Significant therapy effects were also found for secondary PTSD (-related) outcomes, but not for psychosis. Conclusions: In comparison to WL, PE, EMDR, and CR were effective in reducing PTSD symptoms in individuals with PTSD and psychosis, with large effects. Replication in larger samples is needed, although these results support expanding access to trauma therapies in this underserved population.

  • Open Access

    Integrating Wearable Technology in Digital Therapy for People With Psychosis (SloMo): Mixed Methods Co-Design and Feasibility Study

    by Kathryn M Taylor, Thomas Ward, Matteo Cella, Philippa Garety, Amy Grant, Katie Philps, Anna Wojdecka, Melanie Flory, Amy Hardy

    Background: Digital health interventions for psychosis, like SloMo, leverage smartphone technology to help transfer learning from therapy to real-life situations. Usage relies on motivation, recall, and awareness. Wearable devices that track physiological signs of stress can boost engagement by encouraging the use of coping strategies when most needed. Objective: This study aims to co-design an integrated user interface for wearable technology and the SloMo mobile app, and explore its usability, acceptability, engagement, and preliminary clinical outcomes for individuals with psychosis through a feasibility study. Methods: A co-design team developed the wearable augmented SloMo app using the Double Diamond framework. The team included 10 experts by experience based across three UK National Health Service (NHS) mental health trusts, who had completed SloMo as part of a randomized controlled trial, and were purposively recruited to ensure a range of demographic backgrounds. Users tested the app for 8 consecutive weeks during a 5-month data collection period in 2018, providing feedback that guided iterative improvements. Self-reported engagement, usability, and acceptability were collected through quantitative ratings and interviews, evaluated through qualitative content analysis. Assessments of paranoia and well-being were completed pre- and post use, summarized descriptively, with change scores calculated and evaluated for reliable change. Results: The Spire Stone clothing-adhered biosensor, which monitors respiratory rate and stress physiology, was chosen to augment SloMo. A minimum viable product of an integrated interface was developed. Feedback identified that users needed the technology to be easy to use, secure, and tailored to them through user control. Eight (8/10, 80%) users reported that the wearable prompted increased use of the SloMo app’s features and other coping strategies. Self-reported engagement varied according to EBE user experience of the technology: higher use of the technology (n=3) was associated with higher usefulness (25% reduction in paranoia, SD 6%) and acceptability (84% satisfaction, SD 13%). Conversely, individuals that engaged with the device less (n=7) did not find it as useful (11% increase in paranoia, SD 17%) and were only modestly satisfied (63%, SD 20%). Conclusions: Wearable technology is acceptable and can be integrated with a digitally supported therapy for psychosis to promote engagement and potentially support management of difficulties. However, further development work is needed to ensure acceptability and usefulness across a broader range of user needs.

  • Open Access

    Predicting psychological recovery following cognitive-behavioural therapy for psychosis in a naturalistic sample: a machine learning approach

    by Sandra Vieira, Andrew Watson, Nadine Keen, Amy Hardy, Emmanuelle Peters

    Background: Cognitive Behavioural Therapy for psychosis (CBTp) is a recommended treatment;however, not everyone experiences clinical improvements. Predicting personally meaningful recoveryfrom routine data could support personalised care. Methods: This study applied machine learning topredict psychological recovery at the individual level following CBTp in 217 clients from a specialisedpsychological interventions clinic for people with psychosis. Routine pre-therapy demographic information,psychotic symptoms, psychological distress, anxiety, depression, illness perception, functioning, and well-being measures were used to predict an expert-by-experience-led recovery outcome at post-therapy and,in 60 clients, at 6+ months follow-up. Models used repeated cross-validation and elastic-net logisticregression following principal component analysis. Results: At post-therapy, the model achieved 67.9%balanced accuracy and an AUC of 0.71. Balanced accuracy at follow-up was 63.0%. Individuals withpsychotic symptoms accompanied by anxiety, distress, and depressive symptoms, were more likely toshow psychological recovery, whereas those with severe hallucinations and delusions in the absence ofprominent affective distress predicted poorer recovery outcome. Additionally, a CBT-oriented attitudetowards mental health problems was associated with greater improvement, even when accompanied bygreater concern and emotional burden at the beginning of therapy. Gender and ethnicity were notpredictive of psychological recovery, and age not reliably so. Exploratory analyses found no evidence thatprediction errors were associated with distinct psychosocial profiles. Conclusions: Routine clinical datashowed potential for predicting individual psychological recovery following CBTp in a naturalistic setting.

  • Open Access

    The Impact of Trauma-Focused Cognitive Behavior Therapy for Psychosis on Post-Traumatic Stress Symptoms in Daily Life: Experience Sampling Methodology Outcomes of the STAR Trial

    by Morwenna Rickard, Peter Panayi, Amy Hardy, Richard Bentall, Richard Emsley, Craig Steel, Robert Dudley, Raphael Underwood, Ginette Lafit, Clementine J. Edwards, et al.

    Introduction: People with psychosis have high rates of post-traumatic stress disorder (PTSD). The Study of Trauma And Recovery (STAR) randomized controlled trial found that a trauma-focused cognitive behavior therapy for psychosis (TF-CBTp) added to treatment-as-usual (TAU) reduced PTSD symptoms in people with psychosis compared to TAU only. We hypothesized that TF-CBTp would also reduce PTSD symptoms in daily life, using experience sampling methodology (ESM), which would be associated with improvements on a clinical measure of PTSD. Methods: Participants were adults with PTSD and schizophrenia spectrum diagnoses, a subsample of the STAR trial (N = 153; TF-CBTp+TAU = 73, TAU = 80). Participants completed ESM assessments of intrusive memories, hyperarousal, dissociation, avoidance, and negative trauma-related cognitions through a smartphone app multiple times daily over 6 days, at baseline and 9 months post-randomization (end of therapy). Results: No between-group differences were found in ESM measures of momentary PTSD symptoms at 9 months. Significant timepoint × therapy interactions indicated greater decrease over time in hyperarousal, negative cognitions, and avoidance, and in variability of intrusive memories, in TF-CBTp+TAU compared to TAU. ESM measures at 9 months were significantly associated with improvements on the Clinician-Administered PTSD Scale for DSM-5. Conclusion: While findings are tentatively in favor of TF-CBTp, the robust reductions in PTSD symptoms found in the STAR trial using retrospective outcome measures were not fully replicated with ESM, suggesting these methodologies may be capturing different features of symptom expression and processes of therapeutic change. Including both approaches in future research could provide a fuller picture of therapy effects on “in-the-moment” versus reflective reports of experiences.

  • Open Access

    Symptom networks of therapy-seeking individuals with comorbid psychosis and PTSD

    by Rachel Frost, Ciarán O’DRiscoll, Emmanuelle Peters, Filippo Varese, Craig Steel, Raphael Underwood, Sarah Swan, Amy Hardy

    Background: Post-traumatic sequelae are theorized to contribute to and maintain psychotic symptoms. The relative contribution of core posttraumatic stress disorder (PTSD) symptoms and those of complex PTSD are understudied. Network analysis was used to examine interactions between psychosis, core PTSD, and complex post-traumatic symptoms. Based on previous evidence, it was predicted that trauma-related beliefs would have the greatest predictability. It was also hypothesized that the association between voices and trauma-related beliefs would be greater than the association between voices and re-experiencing. Methods: Baseline data from the Study of Trauma and Recovery (STAR), a randomized controlled therapy trial of people with schizophrenia-spectrum disorder who experience distressing delusions and/or hallucinations and comorbid PTSD ( N = 305). A network was estimated using a Bayesian Gaussian graphical model, comprised of psychosis symptoms (delusions and voices), posttraumatic stress symptoms (re-experiencing, avoidance, and sense of threat), complex posttraumatic stress symptoms (affective dysregulation, negative self-concept, disturbed relationships), and trauma-related beliefs (negative cognitions about the self and world, self-blame). A direct acyclic graph was plotted to estimate the potential directionality of associations between symptoms. Results: The hypotheses were not supported. All symptoms had similar predictability scores. There was no evidence for conditionally dependent relations between re-experiencing and voices nor between trauma-related beliefs and voices. However, self-blame was associated with delusions, and affective dysregulation was found to predict voices. Conclusions: Affective dysregulation and self-blame may maintain voices and delusions, respectively. Heterogeneity in trauma-related psychosis could explain inconsistent findings; future research should identify symptom presentation subgroups to improve network reliability.

  • Open Access

    Exploring Psychological and Biological Mediators between Childhood Adversity and Psychosis: An updated Systematic Review and Meta-Analysis

    by Geetanjali Kumar, Ines Lepreux, Lora Bici, Fizza Mustafa, Manuel Abella, Giulia Trotta, Monica Aas, Lucia Sideli, James H MacCabe, Ricardo Twumasi, et al.

    Background: Childhood adversity (CA) has been identified as one of the most robust risk factors for psychotic disorders; several treatable mediating mechanisms have been proposed. Aims: To conduct a systematic review and meta-analysis examining mediating pathways linking CA and psychosis. Method: This PRISMA-compliant systematic review (PROSPERO: CRD42024542972). consisted of a search conducted in January 2026 on Ovid (PsycINFO, Medline, and Embase) using search terms related to psychosis, CA, and mediation analyses. Evidence was appraised by calculating the percentage of the total effect mediated in each study, grouping mediators into meaningful groups. When possible, meta-analyses using two-stage meta-analytic structural equation modelling (METASEM) were conducted. Results: 117 studies were included (54 in clinical samples, 59 in non-clinical samples, and four studies in both clinical and non-clinical samples). 107 studies examined psychological mediators and 12 examined biological. The median percentages of total effect mediated across all analyses per mediator family were: 49% for dissociation (k = 24), 45% for psychosocial stressors (k = 6), 37.9% for negative schemas (k = 23), 35.2% for post-traumatic symptoms (k = 10), 31.5% for depressive symptoms (k = 14), 27.8% for anxiety (k = 11), 27.1% for attachment styles (k = 12), and 8.7% for mentalization domains (k = 5). Meta-analyses confirmed a robust mediating effect of dissociation (k = 7; N = 2143; indirect effect (I.E) =0.42 [0.17, 0.66] on psychosis; 50.49%), on delusions (k =7; N = 1053; I.E = 0.36, [0.27, 0.46]; 46.44%]) and on hallucinations (k =10; N = 5705; I.E = 0.28 [0.20, 0.36]; 57.59%). Robust mediation via depression ( k =5; N= 5028; indirect effect= 0.33 [0.31, 0.35]; 31.05%) and negative schemas of the association between trauma and psychosis broadly defined (k = 7; N=10791; I.E= 0.26 [0.17, 0.35]; 26.36%) was also observed. High heterogeneity was observed across all meta-analyses. Fewer studies examined biological mediators, preventing quantitative synthesis. Conclusions: Childhood adversity impacts psychosis through psychosocial mediators, particularly dissociation. Further work is required to on the potential role of biological mechanisms and its interplay with psychological mechanisms.

  • Open Access

    Author Correction: Digital AVATAR therapy for distressing voices in psychosis: the phase 2/3 AVATAR2 trial

    by Philippa A. Garety, Clementine J. Edwards, Hassan Jafari, Richard Emsley, Mark Huckvale, Mar Rus-Calafell, Miriam Fornells-Ambrojo, Andrew Gumley, Gillian Haddock, Sandra Bucci, et al.

  • Open Access

    Narrative exposure therapy in early intervention in psychosis services (NETp): protocol of a multi-site feasibility randomised controlled trial study

    by Miriam Fornells-Ambrojo, James Plaistow, Amy Hardy, Peter Martin, Natasha Lyons, Zarina Khan, Adeliede Mberi, Tiyi Morris, Sonia Johnson

    Introduction: Cumulative interpersonal traumatisation increases the risk of psychosis and is linked to psychotic symptom severity and reduced recovery rates. Psychosis and treatment themselves can also be traumatising, with a first episode of psychosis posing challenges to one’s identity. Despite a growing evidence base for the safety and effectiveness of trauma therapies for psychosis, implementation remains poor in early intervention for psychosis (EIP) services, partly due to resource constraints. Narrative exposure therapy (NET) is an effective intervention for post-traumatic stress disorder in ethnically diverse populations. Crucially it has potential to address barriers to implementation of trauma therapies in EIP as it has a brief duration with minimal training requirements. This feasibility study will evaluate the feasibility and acceptability of conducting a definite trial of NET in people with early psychosis. Methods and analysis: An individually randomised parallel groups feasibility randomised controlled trial with embedded qualitative evaluation will be conducted. 50 individuals with first episode psychosis and a history of multiple trauma under the care of an EIP service in two NHS trusts in England will be recruited. Participants will be randomised to receive either 15 sessions of NET in addition to treatment as usual or treatment as usual alone. Assessor blinded assessments will be conducted at baseline, 4 months (post-intervention) and 8 months (follow-up). Analyses will focus on feasibility outcomes (recruitment, retention and completion rates) and preliminary estimates of intervention effects to inform planning for a fully powered trial. Qualitative interviews will be carried out with participants allocated to NET and clinicians to investigate acceptability, barriers and facilitators, possible mechanisms of change, potential benefits or harms and recommendations. A sub-study in the NET group will investigate acceptability of completing Experience Sampling Data daily during therapy to monitor changes on candidate primary and secondary outcomes. Ethics and dissemination: This study received REC/HRA ethical approval from the London - City & East Research Ethics Committee (REC) (25/LO/0350). The results of the study will be reported and disseminated at international conferences and in open-access peer-reviewed scientific journals. Trial registration number: ISRCTN39471182 .


  • Open Access

    Feasibility and acceptability of contextually adapted AVATAR therapy for distressing voices in Ethiopia and India: a study protocol for the AVATAR3 study

    by Thomas Ward, Atalay Alem, Thomas K. J. Craig, Koushik Sinha Deb, Surbala Devi, Abebaw Fekadu, Andrew Gumley, Charlotte Hanlon, Rebecca Kelly, Tsegahun Manyazewal, et al.

    Introduction: In many Low- and Middle-Income countries (LMIC), access to psychological therapies for psychosis remains extremely limited, contributing to significant treatment gaps and persistent inequalities in care. Novel interventions that are effective, scalable, and culturally acceptable across diverse settings are urgently needed. AVATAR therapy is an innovative digital intervention for distressing voices in psychosis, developed in the UK. The therapy enables voice-hearers to engage in a series of facilitated dialogues with a customized computer-based representation of their main distressing voice. AVATAR3 represents the first initiative to contextually adapt AVATAR therapy and evaluate its acceptability in two LMIC settings (Ethiopia and India). Methods and analysis: We will establish Innovation and Implementation Hubs in Addis Ababa, Ethiopia (Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa) at Addis Ababa University (AAU) and Mental Health Service Users Association (MHSUA), Ethiopia) and New Delhi, India (All India Institute of Medical Sciences). Phase 1 employs formative work and diverse stakeholder engagement to inform context-specific adaptations. Reflexive thematic analysis will be used, with data synthesis informed by the Cultural Adaptation of Scalable Psychological Interventions (CASPI) framework and Ecological Validity Model (EVM). Phase 2 tests adapted AVATAR therapy through a parallel case series (n=15 per site, targeting 70% completion rate) measuring feasibility, acceptability, and safety indicators at baseline, 12-weeks, and 24-weeks. Qualitative research will explore the experiences of participants (n=10) and therapists (n=8) at each site. Ethics and dissemination: Ethical approval has been obtained from Addis Ababa University College of Health Science Institutional Review Board, All India Institute of Medical Sciences (AIIMS) Institutional Review Board and the King’s College London (study sponsor) Research Ethics Committee. Findings will be disseminated to inform the implementation of AVATAR therapy across diverse international settings. Strengths and limitations of this study: Interdisciplinary and participatory approach Contextual adaptation of a digital innovation Expert by experience leadership and involvement from the conception of the study The study will develop tools and share learning to support future digital mental health innovation across diverse international settings The case-series at each site will not have a control group


  • Open Access

    Wearable augmented digital therapy for people with psychosis (SloMo): Mixed methods co-design study (Preprint)

    by Kathryn M Taylor, Thomas Ward, Matteo Cella, Philippa Garety, Amy Grant, Katie Philps, Anna Wojdecka, Melanie Flory, Amy Hardy

    BACKGROUND Digital health interventions for psychosis, like SloMo, leverage smartphone technology to help transfer learning from therapy to real-life situations. Usage relies on motivation, recall, and awareness. Wearable devices that track physiological signs of stress can boost engagement by encouraging the use of coping strategies when most needed. OBJECTIVE To co-design an integrated user interface for wearable technology and the SloMo mobile app, and to validate its usefulness, usability, and acceptability to individuals with psychosis. METHODS A co-design team, including 10 experts by experience, developed the wearable augmented SloMo app using the Double Diamond framework. Users tested the app for 8 consecutive weeks, providing feedback that guided iterative improvements. User experience ratings and assessments of the technology's potential to reduce paranoia and improve wellbeing were collected pre- and post-use. RESULTS The Spire Stone clothing-adhered biosensor, which monitors respiratory rate and stress physiology, was chosen to augment SloMo. A minimum viable product of an integrated interface was developed. Feedback identified that users needed the technology to be easy to use, secure and tailored to them through user control. Eighty percent of users reported that the wearable prompted increased use of the SloMo app’s features and other coping strategies. Engagement levels and experience varied: those who used the technology most reported improvements to paranoia and high satisfaction. Conversely, individuals that engaged with the device less experienced slight increases in paranoia and were only modestly satisfied. CONCLUSIONS Wearable technology is generally acceptable and can augment a digitally-supported therapy for psychosis and promote engagement. However, further development work is needed for the technology to be acceptable and useful to a broader range of people. CLINICALTRIAL SloMo Trial Registration: ISRCTN 32448671